Stock ZIMLAB ZIM LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News ZIM Laboratories Limited

Equities

ZIMLAB

INE518E01015

Market Closed - Bombay S.E.
Other stock markets
 08:00:38 18/05/2024 BST 		5-day change 1st Jan Change
114 INR +1.29% Intraday chart for ZIM Laboratories Limited -0.91% -1.08%
05-14 Zim Laboratories' Consolidated Profit Climbs in Fiscal Q4; Shares Slide 5% MT
05-13 ZIM Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zim Laboratories' Consolidated Profit Climbs in Fiscal Q4; Shares Slide 5%
MT
ZIM Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
ZIM Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Zim Laboratories Arm Gets License to Operate Business in Dubai, UAE
MT
ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
ZIM Laboratories Limited agreed to acquire 99% stake in Zimtas Pty Ltd for approximately AUD 0.01 million.
CI
CARE Gives BBB Rating to Zim Laboratories' Long-term Bank Financing; Outlook Stable
MT
ZIM Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
ZIM Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
ZIM Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
ZIM Laboratories Issues Over 32 Million Bonus Shares
MT
ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Acuite Retains BBB- Rating on Zim Laboratories' Bank Loans; Raises Outlook to Positive
MT
ZIM Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
ZIM Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
ZIM Laboratories Limited Announces Grant of Marketing Authorization for Sildenafil Citrate 50 mg Orally Dissolving Film in Spain, Europe
CI
ZIM Laboratories Limited Announces Board Changes, Effective April 1, 2022
CI
ZIM Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
CI
ZIM Laboratories : Acuite Ratings & Research Upgrades Zim Laboratories' Rating to BBB-; Keeps Stable Outlook
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZIMLAB Stock
  4. News ZIM Laboratories Limited